Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,193 | 55 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $204.63 | 12 | $0 (2024) |
| Medtronic USA, Inc. | $157.54 | 3 | $0 (2018) |
| Zimmer Biomet Holdings, Inc. | $105.13 | 3 | $0 (2017) |
| CMS Imaging, Inc. | $103.85 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $94.94 | 5 | $0 (2024) |
| PFIZER INC. | $86.31 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $66.55 | 5 | $0 (2024) |
| Daiichi Sankyo Inc. | $51.91 | 3 | $0 (2018) |
| QOL Medical, LLC | $42.04 | 1 | $0 (2024) |
| Allergan Inc. | $31.38 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $258.75 | 13 | PFIZER INC. ($49.10) |
| 2023 | $137.06 | 6 | ABBVIE INC. ($45.66) |
| 2021 | $103.85 | 1 | CMS Imaging, Inc. ($103.85) |
| 2020 | $13.44 | 1 | Boston Scientific Corporation ($13.44) |
| 2019 | $99.93 | 7 | AbbVie, Inc. ($39.50) |
| 2018 | $392.86 | 18 | Medtronic USA, Inc. ($157.54) |
| 2017 | $186.82 | 9 | Zimmer Biomet Holdings, Inc. ($105.13) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Gastroenterology | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/23/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/19/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Immunology | ||||||
| 04/26/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Immunology | ||||||
| 03/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/14/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/15/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $42.04 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/22/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Gastroenterology | ||||||
| 08/22/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/04/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Urology | ||||||
| 02/06/2023 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/10/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/24/2021 | CMS Imaging, Inc. | — | Food and Beverage | Cash or cash equivalent | $103.85 | General |
| 01/29/2020 | Boston Scientific Corporation | GENERAL - ENDOCHOICE (Device) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: ENDOCHOICE | ||||||
| 10/17/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Immunology | ||||||
| 07/15/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/12/2019 | Boston Scientific Corporation | ACQUIRE (Device) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: BIOPSY | ||||||
| 05/13/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,338 | 1,459 | $847,215 | $159,398 |
| 2022 | 18 | 1,556 | 1,776 | $887,215 | $177,803 |
| 2021 | 23 | 1,606 | 1,855 | $934,115 | $190,583 |
| 2020 | 19 | 1,408 | 1,686 | $800,705 | $162,829 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 182 | 183 | $183,000 | $35,994 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 240 | 334 | $51,770 | $27,830 | 53.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 251 | 253 | $174,570 | $17,726 | 10.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 157 | 159 | $146,280 | $15,161 | 10.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 128 | 128 | $32,640 | $14,674 | 45.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 70 | 70 | $59,500 | $11,903 | 20.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 11 | 11 | $22,000 | $5,982 | 27.2% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $32,650 | $4,871 | 14.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 28 | 28 | $23,800 | $4,717 | 19.8% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 25 | 25 | $35,000 | $3,825 | 10.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 28 | 28 | $23,800 | $3,608 | 15.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 52 | $5,200 | $3,012 | 57.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $6,000 | $2,625 | 43.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 39 | $4,095 | $2,334 | 57.0% |
| 43450 | Dilation of esophagus | Facility | 2023 | 70 | 70 | $21,700 | $2,119 | 9.8% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $13,910 | $2,076 | 14.9% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 17 | 20 | $11,300 | $942.23 | 8.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 333 | 471 | $73,005 | $41,393 | 56.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 209 | 209 | $209,000 | $40,160 | 19.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 262 | 265 | $182,850 | $18,311 | 10.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 172 | 173 | $159,160 | $15,015 | 9.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 130 | 130 | $33,150 | $14,526 | 43.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 65 | 65 | $55,250 | $11,457 | 20.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 58 | 134 | $14,070 | $7,249 | 51.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 42 | $12,600 | $6,351 | 50.4% |
About Dr. Marc Noble, MD
Dr. Marc Noble, MD is a Gastroenterology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619930807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Noble, MD has received a total of $1,193 in payments from pharmaceutical and medical device companies, with $258.75 received in 2024. These payments were reported across 55 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,193).
As a Medicare-enrolled provider, Noble has provided services to 5,908 Medicare beneficiaries, totaling 6,776 services with total Medicare billing of $690,613. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Specialist
- Location Charleston, SC
- Active Since 04/10/2006
- Last Updated 05/07/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1619930807
Products in Payments
- INTERSTIM ICON (Device) $138.15
- XELJANZ (Drug) $86.31
- Creon (Drug) $74.50
- Zimmer Abutments (Device) $67.33
- STELARA (Biological) $66.55
- LINZESS (Drug) $64.06
- Humira (Biological) $53.07
- INTERSTIM (Device) $50.19
- SUCRAID (Drug) $42.04
- CREON (Drug) $41.82
- Bellatek (Device) $37.80
- INJECTAFER (Drug) $35.60
- TRULANCE (Drug) $33.47
- HYRIMOZ (Biological) $30.27
- UCERIS TABLETS (Drug) $24.48
- ZENPEP (Drug) $23.57
- XIFAXAN (Drug) $22.71
- Alinia Tablets 500mg 30 count bottle (Drug) $22.36
- Trulance (Drug) $20.96
- IBSRELA (Drug) $20.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Charleston
Mark Delegge, Md, MD
Gastroenterology — Payments: $666,913
Erin Forster, M.d, M.D
Gastroenterology — Payments: $597,594
Don Rockey, Md, MD
Gastroenterology — Payments: $593,484
Peter Cotton, Md, MD
Gastroenterology — Payments: $519,256
Dr. John Litchfield, Do, DO
Gastroenterology — Payments: $42,542
Brenda Hoffman, Md, MD
Gastroenterology — Payments: $17,605